Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Oncology
  4. Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression

Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression

Frontiers in Cell and Developmental Biology, 2022 · DOI: 10.3389/fcell.2022.1065837 · Published: December 23, 2022

OncologyGenetics

Simple Explanation

Retinoblastoma (RB) is a childhood eye cancer where early stages can be controlled but metastasis leads to high mortality. Non-coding RNAs (ncRNAs) affect cell processes like differentiation and proliferation, and their deregulation is linked to cancer, including RB. Some ncRNAs, such as miR-491-3p, act as tumor suppressors in RB, while others, like circ-E2F3, promote tumor growth. Understanding how ncRNAs regulate RB could offer new treatment options. This review discusses the roles of important ncRNAs in RB, their interactions with genes responsible for RB development, and their potential clinical uses for diagnosis, prognosis, or therapy.

Study Duration
Not specified
Participants
Retinoblastoma cell lines and tissues from patients
Evidence Level
Review

Key Findings

  • 1
    miR-491-3p acts as a tumor suppressor gene in RB, inhibiting the growth and metastasis of tumors by targeting SNN.
  • 2
    miR-340 promotes RB cell proliferation, migration, and invasion by targeting WIF1.
  • 3
    Circ-E2F3 promotes RB progression via the miR-204-5p/ROCK1 axis.

Research Summary

Non-coding RNAs (ncRNAs) play a crucial role in various cellular processes, and their deregulation is associated with retinoblastoma (RB) progression. Several ncRNAs act as tumor suppressors or promoters in RB. MicroRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) have been found to influence RB development through various mechanisms, including acting as miRNA sponges and regulating gene expression. Exosomal ncRNAs, such as miR-92a-3p and miR-142-3p, contribute to RB tumor angiogenesis and growth. These ncRNAs can be delivered to other cells, influencing the tumor microenvironment.

Practical Implications

Diagnostic Biomarkers

ncRNAs can serve as prognostic or diagnostic biomarkers for retinoblastoma.

Therapeutic Targets

ncRNAs can be targeted in therapeutic regimens for RB.

Exosomal ncRNA Therapy

Exosomal ncRNAs could be utilized for therapeutic purposes in RB treatment.

Study Limitations

  • 1
    Limited clinical applications of ncRNAs have been evaluated.
  • 2
    Several ncRNAs can have opposite functions across various cancer types.
  • 3
    Regulatory roles of ncRNAs and their related mechanisms in RB need further identification.

Your Feedback

Was this summary helpful?

Back to Oncology